Many studies already reported on the association between patient characteristics on the severity of COVID-19 disease outcome, but the relation with SARS-CoV-2 antibody levels is less clear. To investigate this in more detail, we performed a retrospective observational study in which we used the IgG antibody response from 11,118 longitudinal antibody measurements of 2,082 unique COVID convalescent plasma donors. COVID-19 symptoms and donor characteristics were obtained by a questionnaire. Antibody responses were modelled using a linear mixed-effects model. Our study confirms that the SARS-CoV-2 antibody response is associated with patient characteristics like body mass index and age. Antibody decay was faster in male than in female donors (a...
In addition to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), humans are also suscept...
OBJECTIVE: To determine clinical and ethnodemographic correlates of serological responses against th...
This contribution explores in a new statistical perspective the antibody responses to severe acute r...
Many studies already reported on the association between patient characteristics on the severity of ...
SARS-CoV-2 pandemic is causing high morbidity and mortality burden worldwide with unprecedented stra...
Objectives: Characterisation of the human antibody response to SARS-CoV-2 infection is vital for ser...
Biobanks are instrumental for accelerating research. Early in SARS-CoV-2 pandemic, the Argentinean B...
Introduction: There is a need for detailed data on early antibody responses against SARS-CoV-2 as th...
Introduction: The continued spread of corona virus disease 2019 (COVID-19) has prompted widespread c...
BackgroundThe novel coronavirus disease 2019 (COVID-19), caused by the severe acute respiratory synd...
Despite intensive research, the physiology of the serological response to SARS-CoV-2 infection and i...
International audienceConvalescent plasma therapy has been described as an attractive approach to tr...
Background: SARS‑CoV‑2 emerged in China and spread throughout the world due to its rapid transmissio...
Background/Aim: The relationship between the kinetics of antibody responses to severe acute respirat...
\(\bf Background\) The novel coronavirus disease 2019 (COVID-19), caused by the severe acute respir...
In addition to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), humans are also suscept...
OBJECTIVE: To determine clinical and ethnodemographic correlates of serological responses against th...
This contribution explores in a new statistical perspective the antibody responses to severe acute r...
Many studies already reported on the association between patient characteristics on the severity of ...
SARS-CoV-2 pandemic is causing high morbidity and mortality burden worldwide with unprecedented stra...
Objectives: Characterisation of the human antibody response to SARS-CoV-2 infection is vital for ser...
Biobanks are instrumental for accelerating research. Early in SARS-CoV-2 pandemic, the Argentinean B...
Introduction: There is a need for detailed data on early antibody responses against SARS-CoV-2 as th...
Introduction: The continued spread of corona virus disease 2019 (COVID-19) has prompted widespread c...
BackgroundThe novel coronavirus disease 2019 (COVID-19), caused by the severe acute respiratory synd...
Despite intensive research, the physiology of the serological response to SARS-CoV-2 infection and i...
International audienceConvalescent plasma therapy has been described as an attractive approach to tr...
Background: SARS‑CoV‑2 emerged in China and spread throughout the world due to its rapid transmissio...
Background/Aim: The relationship between the kinetics of antibody responses to severe acute respirat...
\(\bf Background\) The novel coronavirus disease 2019 (COVID-19), caused by the severe acute respir...
In addition to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), humans are also suscept...
OBJECTIVE: To determine clinical and ethnodemographic correlates of serological responses against th...
This contribution explores in a new statistical perspective the antibody responses to severe acute r...